Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Exo Therapeutics
Exo Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Exo Therapeutics
Total Funding
$103 M
Exo Therapeutics Summary
Company Summary
Overview
Exo Therapeutics is a company engaged in molecule drug discovery and development. It offers ExoSight, a platform for targeting and identifying exosites that modulate enzyme activity and discovering therapeutic candidates for disease treatment.
Type
Private
Status
Active
Founded
2018
HQ
Cambridge, MA, US
|
view all locations
Website
https://exo-therapeutics.com/
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
Homepage
Linkedin
twitter
Table of Contents
Key People
Locations
Competitors
Key People
Dorothy Lou Bailey,
Chief Operating Officer and President
Linkedin
Alan Saghatelian,
Co-Founder
Linkedin
Alexandra Joseph,
Executive Vice President, Biology
Linkedin
Bob Fay,
Vice President, Facilities Operations
Linkedin
and 4 others
Locations
View all
1 location detected
Cambridge, MA
HQ
United States
150 Cambridgepark Dr #300
Competitors and Similar Companies
Walvax Biotechnology
Healthcare - Public
Serum Institute of India
Healthcare - Subsidiary
The Searle Company
Healthcare - Private
Shandong Saito Biotechnology
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top